US 11058688
Imidazopiperazine inhibitors of transcription activating proteins
granted A61KA61K31/4985A61K31/5377
Quick answer
US patent 11058688 (Imidazopiperazine inhibitors of transcription activating proteins) held by The Board of Regents of the University of Texas System expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K31/4985, A61K31/5377